Cargando…

Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082

Detalles Bibliográficos
Autores principales: Rizzo, Maria Rosaria, Barbieri, Michelangela, Marfella, Raffaele, Paolisso, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526208/
https://www.ncbi.nlm.nih.gov/pubmed/23264296
http://dx.doi.org/10.2337/dc12-1436
_version_ 1782253519186690048
author Rizzo, Maria Rosaria
Barbieri, Michelangela
Marfella, Raffaele
Paolisso, Giuseppe
author_facet Rizzo, Maria Rosaria
Barbieri, Michelangela
Marfella, Raffaele
Paolisso, Giuseppe
author_sort Rizzo, Maria Rosaria
collection PubMed
description
format Online
Article
Text
id pubmed-3526208
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35262082014-01-01 Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 Rizzo, Maria Rosaria Barbieri, Michelangela Marfella, Raffaele Paolisso, Giuseppe Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526208/ /pubmed/23264296 http://dx.doi.org/10.2337/dc12-1436 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Comments and Responses
Rizzo, Maria Rosaria
Barbieri, Michelangela
Marfella, Raffaele
Paolisso, Giuseppe
Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_full Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_fullStr Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_full_unstemmed Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_short Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_sort response to comment on: rizzo et al. reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-iv inhibition. diabetes care 2012;35:2076–2082
topic Online Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526208/
https://www.ncbi.nlm.nih.gov/pubmed/23264296
http://dx.doi.org/10.2337/dc12-1436
work_keys_str_mv AT rizzomariarosaria responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT barbierimichelangela responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT marfellaraffaele responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT paolissogiuseppe responsetocommentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082